Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Hansa Biopharma Reports Third Quarter and Interim Year to Date 2026 Financial Results
      Biotech

      Hansa Biopharma Reports Third Quarter and Interim Year to Date 2026 Financial Results

      November 11, 2026
      Neurocrine Biosciences to Present at the 2026 Jefferies Global Healthcare Conference
      Biotech

      Neurocrine Biosciences to Present at the 2026 Jefferies Global Healthcare Conference

      November 10, 2026
      INOVIO Reports Third Quarter 2026 Financial Results and Recent Business Highlights
      Biotech

      INOVIO Reports Third Quarter 2026 Financial Results and Recent Business Highlights

      November 10, 2026
      Immutep Further Expands United States Patent Estate for Efti-Based Combination Therapies
      Biotech

      Immutep Further Expands United States Patent Estate for Efti-Based Combination Therapies

      November 10, 2026
      Neuronetics Announces Pricing of $30 Million Underwritten Public Offering of Common Stock
      Biotech

      Neuronetics Announces Pricing of $30 Million Underwritten Public Offering of Common Stock

      November 10, 2026
      Nuvation Bio to Present at the Jefferies Global Healthcare Conference in London
      Biotech

      Nuvation Bio to Present at the Jefferies Global Healthcare Conference in London

      November 10, 2026
      Azenta Reports Fourth Quarter and Full Year Results for Fiscal 2026, Ended September 30, 2026.
      Biotech

      Azenta Reports Fourth Quarter and Full Year Results for Fiscal 2026, Ended September 30, 2026.

      November 10, 2026
      Compugen Reports Third Quarter 2026 Results
      Biotech

      Compugen Reports Third Quarter 2026 Results

      November 10, 2026
      Viking Therapeutics Announces Two Poster Presentations at ObesityWeek® 2026
      Biotech

      Viking Therapeutics Announces Two Poster Presentations at ObesityWeek® 2026

      November 10, 2026
      Zimmer Biomet to Present at the Annual Jefferies Global Healthcare Conference in London
      Biotech

      Zimmer Biomet to Present at the Annual Jefferies Global Healthcare Conference in London

      November 10, 2026
      « 1 … 6 7 8 9 10 … 176 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026